DE69826711D1 - Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie - Google Patents

Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie

Info

Publication number
DE69826711D1
DE69826711D1 DE69826711T DE69826711T DE69826711D1 DE 69826711 D1 DE69826711 D1 DE 69826711D1 DE 69826711 T DE69826711 T DE 69826711T DE 69826711 T DE69826711 T DE 69826711T DE 69826711 D1 DE69826711 D1 DE 69826711D1
Authority
DE
Germany
Prior art keywords
cancer cells
photodynamic therapy
treating
cells
cancerous cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69826711T
Other languages
English (en)
Other versions
DE69826711T2 (de
Inventor
A Rodgers
Giulio Jori
E Kenney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bowling Green State University
Original Assignee
Bowling Green State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bowling Green State University filed Critical Bowling Green State University
Publication of DE69826711D1 publication Critical patent/DE69826711D1/de
Application granted granted Critical
Publication of DE69826711T2 publication Critical patent/DE69826711T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69826711T 1997-11-12 1998-11-12 Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie Expired - Fee Related DE69826711T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/999,866 US6071944A (en) 1997-11-12 1997-11-12 Method of treatment of pigmented cancer cells utilizing photodynamic therapy
US999866 1997-11-12
PCT/US1998/024153 WO1999023882A1 (en) 1997-11-12 1998-11-12 Method of treatment of pigmented cancer cells utilizing photodynamic therapy

Publications (2)

Publication Number Publication Date
DE69826711D1 true DE69826711D1 (de) 2004-11-04
DE69826711T2 DE69826711T2 (de) 2006-02-23

Family

ID=25546723

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69826711T Expired - Fee Related DE69826711T2 (de) 1997-11-12 1998-11-12 Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie

Country Status (7)

Country Link
US (2) US6071944A (de)
EP (1) EP1037531B1 (de)
AT (1) ATE277515T1 (de)
AU (1) AU1403399A (de)
CA (1) CA2310590A1 (de)
DE (1) DE69826711T2 (de)
WO (1) WO1999023882A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9710049D0 (en) * 1997-05-19 1997-07-09 Nycomed Imaging As Method
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
JP2002534218A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US6624187B1 (en) 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
US6887862B2 (en) 2001-05-31 2005-05-03 Miravant Systems, Inc. Method for improving treatment selectivity and efficacy using intravascular photodynamic therapy
GB0113899D0 (en) 2001-06-07 2001-08-01 Photocure Asa Photodynamic therapy lamp
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7223282B1 (en) * 2001-09-27 2007-05-29 Advanced Cardiovascular Systems, Inc. Remote activation of an implantable device
JP2005527493A (ja) * 2002-01-23 2005-09-15 ライト サイエンシーズ コーポレイション 光線力学療法のためのシステムおよび方法
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
AU2003282683A1 (en) * 2002-10-04 2004-05-04 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US20110040295A1 (en) * 2003-02-28 2011-02-17 Photometics, Inc. Cancer treatment using selective photo-apoptosis
US7354433B2 (en) * 2003-02-28 2008-04-08 Advanced Light Technologies, Llc Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy
US8211883B2 (en) 2004-04-01 2012-07-03 Case Western Reserve University Topical delivery of phthalocyanines
US20060234959A1 (en) * 2005-04-14 2006-10-19 Advanced Photodynamic Technologies, Inc. Photodynamic therapy utilizing multiple duty cycle light modulation
WO2007020649A2 (en) * 2005-08-17 2007-02-22 Y.K. Holdings Ltd. Lice extermination system and method
US9358292B2 (en) * 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
US20090104212A1 (en) * 2007-08-06 2009-04-23 Immunolight Methods and systems for treating cell proliferation disorders using two-photon simultaneous absorption
TWI574712B (zh) * 2008-02-21 2017-03-21 伊穆諾萊特公司 利用電漿子增強之光譜療法（ｐｅｐｓｔ）及激子-電漿增強之光療法（ｅｐｅｐ）治療細胞增生病症之組合物及產生自體疫苗之系統
WO2013009688A1 (en) 2011-07-08 2013-01-17 Bourke Frederic A Phosphors and scintillators for light stimulation within a medium
CN113274496A (zh) * 2008-04-04 2021-08-20 免疫之光有限责任公司 用于原位光生物调节的非侵入性系统和方法
US8440641B2 (en) 2009-03-20 2013-05-14 Case Western Reserve University Phthalocyanine salt formulations
KR101385196B1 (ko) 2012-05-17 2014-04-14 주식회사 유니크메디케어 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법

Also Published As

Publication number Publication date
US6225333B1 (en) 2001-05-01
EP1037531A4 (de) 2002-06-26
WO1999023882A1 (en) 1999-05-20
DE69826711T2 (de) 2006-02-23
EP1037531A1 (de) 2000-09-27
EP1037531B1 (de) 2004-09-29
US6071944A (en) 2000-06-06
ATE277515T1 (de) 2004-10-15
AU1403399A (en) 1999-05-31
CA2310590A1 (en) 1999-05-20

Similar Documents

Publication Publication Date Title
ATE277515T1 (de) Verfahren zur behandlung von pigmentierten krebszellen durch photodynamische therapie
DE69532160D1 (de) Verfahren zur phototherapeutischen behandlung von proliferativen hauterkrankungen
GB9110651D0 (en) Composition and method of enhancing sun tanning
NZ334190A (en) Method for improved selectivity in photo-activation of molecular agents
MY121548A (en) Compounds and methods for the treatment of cancer
ES2160173T3 (es) Nuevo derivado de rodamina para la terapia fotodinamica de cancer y purgacion en vitro de leucemia.
AU732673C (en) Device for the photodynamic treatment of living beings and of the organs thereof
ATE296839T1 (de) Antikörper zur krebsbehandlung und -diagnose
ATE353657T1 (de) Verwendung von immunerregenden oligonukleotiden zur vorbeugung oder behandlung von asthma
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
PL362795A1 (en) Photochemical internalization for virus-mediated molecule delivery into the cyosol
ATE404226T1 (de) Zusammensetzung enthaltend auf festen teilchen immobilisierte radioisotopen, sowie deren verwendung in der brachytherapie
ZA923561B (en) Composition and method of treating depigmentation disorders
CA2253207A1 (en) Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
DE3485282D1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
ATE192234T1 (de) Verfahren zur bestimmung der phototoxizität und/oder photosensibilität von stoffen oder stoffgemischen sowie dessen verwendung
IT1244459B (it) Composizione terapeutica per il trattamento di malattie della pelle quali vitiligine,acne,psoriasi,alopecia,ipotricosi
RU95118494A (ru) Способ лечения летней формы псориаза
RU93048505A (ru) Способ лечения рака молочной железы
RU97111568A (ru) Способ лечения онкологических больных

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee